Accure Therapeutics

Accure Therapeutics is committed to discovering and developing novel drugs for treating patients with severe central nervous system diseases. Accure Therapeutics focuses on dysfunctional neurons and the glial environment that supports them, aiming to halt their degeneration and death. They strive to find new drugs capable of correcting pathological changes causing the disease and producing beneficial outcomes (e.g., disease-modifying therapies). By combining the latest advances in neurobiology with cutting-edge clinical research, they specialize in developing drugs that promote neuroprotection and neurorepair. Currently, they have established a portfolio of drug candidates targeting four areas: optic neuritis, multiple sclerosis, Parkinson's disease, and epilepsy.